Rooibos tea (Aspalathus linearis) is a well-known South African herbal tea enjoyed worldwide. Limited reports indicate the potential of rooibos tea to alter the activity of certain cytochrome P450 (CYP450) isozymes. In this study, the phytochemical investigation of MeOH extract of A. linearis (leaves and stems) resulted in the isolation and characterization of 11 phenolic compounds. The MeOH extract exhibited significant inhibition of the major human CYP450 isozymes (CYP3A4, CYP1A2, CYP2D6, CYP2C9, and CYP2C19). The strongest inhibition was observed by the extract for CYP3A4 (IC 50 1.7 ± 0.1 μg/mL) followed by CYP2C19 (IC 50 4.0 ± 0.3 μg/mL). Among the tested phytochemicals, the most potent inhibitors were isovitexin on CYP3A4 (IC 50 3.4 ± 0.2 μM), vitexin on CYP2C9 (IC 50 8.0 ± 0.2 μM), and thermopsoside on CYP2C19 (IC 50 9.5 ± 0.2 μM). The two major, structurally related compounds aspalathin and nothofagin exhibited a moderate pregnane-X receptor (PXR) activation, which was associated with increased mRNA expression of CYP3A4 and CYP1A2, respectively. These results indicate that a high intake of nutraceuticals containing rooibos extracts may pose a risk of herb−drug interactions when consumed concomitantly with clinical drugs that are substrates of CYP enzymes.

No abstract

No abstract

A new rearranged clerodane diterpenoid, tinocrispide was isolated from the stems of Tinospora crispa along with thirteen known compounds including eight clerodane diterpenoids. Among the known compounds baenzigeride A, (6S, 9R)-vomifoliol and steponine are being reported for the first time from T. crispa. Their structures were elucidated by 1D and 2D NMR and confirmed by HRESIMS. The 13 C NMR data of borapetol A has been revised.